The Potential of FDA-Approved Drugs for Alcohol Use Disorder

7min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter explores the existence of FDA-approved drugs for alcohol use disorder, their effectiveness, and the reasons for their low usage. It also discusses the potential use of a drug called semaglutide and the possibility of adding it to the list of drugs for alcohol use disorder.

Divisions within the ruling party are on full display this week, and the provocative policies Prime Minister Rishi Sunak announced are unlikely to help the Conservatives’ woeful polling numbers. Early results suggest that new drugs initially prescribed for weight loss may be a powerful treatment for alcohol-use disorder (13:06). And a data dive reveals which countries get the most sleep (20:05)

Sign up for Economist Podcasts+ now and get 50% off your subscription with our limited time offer. You will not be charged until Economist Podcasts+ launches.

Visit http://www.economist.com/podcastsplus-intelligence to join.

If you’re already a subscriber to The Economist, you’ll have full access to all our shows as part of your subscription.

For more information about Economist Podcasts+, including how to get access, please visit our FAQs page.